infliximab

Trials studying infliximab

• phase2Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-I)recruitingn=240
• —A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Diseaseactive not recruitingn=4,970
• phase3A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitisactive not recruitingn=84
• phase3Precise Infliximab Exposure and Pharmacodynamic Controlrecruitingn=180
• N/ASequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantationcompletedn=20
• —Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)completedn=77
• phase2EPIC- Extracorporeal Photopheresis (ECP) for Immune-related Colitiswithdrawn
• phase3A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)completedn=330